The role of diet in multiple sclerosis;Rola diety w stwardnieniu rozsianym

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 68, Issue , 2014, Pages 325-333

  Konikowska, Klaudia ^a   Regulska Ilow, Bozena ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Multiple sclerosis; Nutrition; Omega 3; Oxidative stress; Swank; Vitamin D

Indexed keywords

ANTIOXIDANT; FOLIC ACID; OMEGA 3 FATTY ACID; VITAMIN;

COMPLICATION; CYANOCOBALAMIN DEFICIENCY; DAIRY PRODUCT; DIET SUPPLEMENTATION; DIET THERAPY; FOLIC ACID DEFICIENCY; HUMAN; MULTIPLE SCLEROSIS; VEGETABLE; VITAMIN D DEFICIENCY;

ANTIOXIDANTS; DAIRY PRODUCTS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; MULTIPLE SCLEROSIS; VEGETABLES; VITAMIN B 12 DEFICIENCY; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84911940408     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1095838     Document Type: Review

References (42)

1. About the Swank low-fat diet for the treatment of MS. http://www.swankmsdiet.org/About%20The%20Diet (02.04.2012)
2. Andersen R., Mølgaard C., Skovgaard L.T., Brot C., Cashman K.D., Chabros E., Charzewska J., Flynn A., Jakobsen J., Kärkkäinen M., Kiely M., Lamberg-Allardt C., Moreiras O., Natri A.M., O'Brien M., Rogalska- Niedzwiedz M., Ovesen L.: Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur. J. Clin. Nutr., 2005; 59: 533-541
3. Ascherio A., Munger K.L.: Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann. Neurol., 2007; 61: 504-513
4. Baranzini S.E., Galwey N.W., Wang J., Khankhanian P., Lindberg R., Pelletier D., Wu W., Uitdehaag B.M., Kappos L., GeneMSA Consortium, Polman C.H., Matthews P.M., Hauser S.L., Gibson R.A., Oksenberg J.R., Barnes M.R.: Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet., 2009; 18: 2078-2090
5. Besler H.T., Comoʇlu S.: Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr. Neurosci., 2003; 6: 189-196
6. Besler H.T., Comoʇlu S., Okcu Z.: Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr. Neurosci., 2002; 5: 215-220
7. Bolesławska I., Grygiel-Górniak B., Przysławski J.: Zywieniowe aspekty rozwoju osteoporozy ws̈ród kobiet i męzczyzn z regionu Wielkopolski. Now. Lek., 2006; 75: 27-30
8. Cameron M.H., Lord S.: Postular control in multiple sclerosis: implications for fall prevention. Curr. Neurol. Neurosci. Rep., 2010; 10: 407-412
9. Charzewska J., Weker H.: Ogólnopolskie badanie nad zawartos̈cią wapnia i witaminy D w dietach dzieci w wieku 4 lat. Pediatr. Współcz. Gastroenter., 2006; 8: 107-109
10. Compston A., Coles A.: Multiple sclerosis. Lancet, 2002; 359: 1221-1231
11. de Bustos F., Jiménez-Jiménez F.J., Molina J.A., Gómez-Escalonilla C., de Andrés C., del Hoyo P., Zurdo M., Tallón-Barranco A., Berbel A., Porta-Etessam J., Parrilla G., Arenas J.: Serum levels of coenzyme Q10 in patients with multiple sclerosis. Acta Neurol. Scand., 2000; 101: 209-211
12. Dworzańska E., Mitosek-Szewczyk K., Stelmasiak Z.: Zespół zmęczenia w stwardnieniu rozsianym. Neurol. Neurochir. Pol., 2009; 43: 71-76
13. Fryze W., Mirowska-Guzel D., Wiszniewska M., Darda-Ledzion L., Członkowski A., Członkowska A.: Alternative methods of treatment used by multiple sclerosis patients in Poland. Neurol. Neurochir. Pol., 2006; 40: 386-390
14. Ghadirian P., Jain M., Ducic S., Shatenstein B., Morisset R.: Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int. J. Epidemiol., 1998; 27: 845-852
15. Hadžović-Džuvo A., Lepara O., Valjevac A., Avdagić N., Hasić S., Kiseljaković E., Ibragić S., Alajbegović A.: Serum total antioxidant capacity in patients with multiple sclerosis. Bosn. J. Basic Med. Sci., 2011; 11: 33-36
16. Jas̈kiewicz E.: Epitopy na białkach mieliny rozpoznawane przez autoprzeciwciała obecne u chorych na stwardnienie rozsiane. Postępy Hig. Med. Dos̈w., 2004; 58: 472-482
17. Kampman M.T., Wilsgaard T., Mellgren S.I.: Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J. Neurol., 2007; 254: 471-477
18. Kierzek A.: Benni, Babiński, Bouchard, Charcot. Ich wkład do rozwoju stosunków XIX-wiecznej medycyny polskiej i francuskiej. Przegl. Lek., 2007; 64: 183-184
19. Krótkie fakty o SM. Multiple Sclerosis International Federation. http:www.msif.org/pl/quick-facts/index.html (02.04.2012)
20. Leong E.M., Semple S.J., Angley M., Siebert W., Petkov J., McKinnon R.A.: Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complement. Ther. Med., 2009; 17: 216-223
21. Mahon B.D., Gordon S.A., Cruz J., Cosman F., Cantorna M.T.: Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J. Neuroimmunol., 2003; 134: 128-132
22. Miller A., Korem M., Almog R., Galboiz Y.: Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J. Neurol. Sci., 2005; 233: 93-97
23. Miller E., Mrowicka M., Zołyński K., Kędziora J.: Stres oksydacyjny w stwardnieniu rozsianym. Pol. Merkur. Lekarski, 2009; 27: 499-502
24. Mirzaei F., Michels K.B., Munger K., O'Reilly E., Chitnis T., Forman M.R., Giovannucci E., Rosner B., Ascherio A.: Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann. Neurol., 2011; 70: 30-40
25. Munger K.L., Chitnis T., Frazier A.L., Giovannucci E., Spiegelman D., Ascherio A.: Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J. Neurol., 2011; 258: 479-485
26. Nordvik I., Myhr K.M., Nyland H., Bjerve K.S.: Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol. Scand., 2000; 102: 143-149
27. Nortvedt M.W., Riise T., Mæland J.G.: Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurol. Sci., 2005; 26: 334-339
28. Pekmezovic T.D., Kisic Tepavcevic D.B., Mesaros S.T., Dujmovic Basuroski I.B., Stojsavljevic N.S., Drulovic J.S.: Food and dietary patterns and multiple sclerosis: a case-control study in Belgrade (Serbia). Ital. J. Public Health, 2009; 6: 81-87
29. Ramagopalan S.V., Dyment D.A., Guimond C., Orton S.M., Yee I.M., Ebers G.C., Sadovnick A.D.: Childhood cow's milk allergy and the risk of multiple sclerosis: a population based study. J. Neurol. Sci., 2010; 291: 86-88
30. Ramagopalan S.V., Sadovnick A.D.: Epidemiology of multiple sclerosis. Neurol. Clin., 2011; 29: 207-217
31. Ramsaransing G.S., Fokkema M.R., Teelken A., Arutjunyan A.V., Koch M., De Keyser J.: Plasma homocysteine levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 2006; 77: 189-192
32. Ramsaransing G.S., Mellema S.A., De Keyser J.: Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory study. Nutr. J., 2009; 8: 36
33. Risberg G., Aarseth J.H., Nyland H., Lauer K., Myhr K.M., Midgard R.: Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurol. Scand., 2011; 124: 250-257
34. Swank R.L., Dugan B.B.: Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet, 1990; 336: 37-39
35. Swank R.L., Goodwin J.: Review of MS patient survival on a Swank low saturated fat diet. Nutrition, 2003; 19: 161-162
36. Triantafyllou N., Evangelopoulos M.E., Kimiskidis V.K., Kararizou E., Boufidou F., Fountoulakis K.N., Siamouli M., Nikolaou C., Sfagos C., Vlaikidis N., Vassilopoulos D.: Increased plasma homocysteine levels in patients with multiple sclerosis and depression. Ann. Gen. Psychiatry, 2008; 7: 17
37. van der Mei I.A., Ponsonby A.L., Dwyer T., Blizzard L., Simmons R., Taylor B.V., Butzkueven H., Kilpatrick T.: Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ, 2003; 327: 316
38. Weinstock-Guttman B., Baier M., Park Y., Feichter J., Lee-Kwen P., Gallagher E., Venkatraman J., Meksawan K., Deinehert S., Pendergast D., Awad A.B., Ramanathan M., Munschauer F., Rudick R.: Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot. Essent. Fatty Acids, 2005; 73: 397-404
39. Willer C.J., Dyment D.A., Sadovnick A.D., Rothwell P.M., Murray T.J., Ebers G.C.; Canadian Collaborative Study Group: Timing of birth and risk of multiple sclerosis: population based study. BMJ, 2005; 330: 120
40. Wingerchuk D.M., Lesaux J., Rice G.P., Kremenchutzky M., Ebers G.C.: A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 2005; 76: 1294-1296
41. Yadav V., Shinto L., Morris C., Senders A., Baldauf-Wagner S., Bourdette D.: Use and self-reported benefit of complementary and alternative medicine among multiple sclerosis patients. Int. J. MS Care, 2006; 8: 5-10
42. Zhang S.M., Hernán M.A., Olek M. J., Spiegelman D., Willett W.C., Ascherio A.: Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women. Neurology, 2001; 57: 75-80